Aminocaproic Acid

Aminocaproic acid is a medicine used to help stop heavy bleeding. It works by keeping blood clots from breaking down too fast. It can be taken as a pill or liquid by mouth, or given through an IV in the hospital.

Brand names:Amicar
Medication

What people taking Aminocaproic Acid report

Every report comes from a Lived member, sent anonymously.

Have you tried Aminocaproic Acid for von Willebrand Disease?

NameHow it went

About Aminocaproic Acid

What It's For

Aminocaproic acid, sold as Amicar tablets and oral solution and also as generic tablets, liquid and an IV (intravenous) injection, is a prescription medicine that helps control bleeding when the body is breaking down blood clots too quickly. This excess clot breakdown is called fibrinolysis. It belongs to a group of medicines called antifibrinolytics. The US label covers bleeding in which fibrinolysis plays a part. That can happen after heart surgery, with or without a heart-lung bypass machine, and after a portacaval shunt (liver surgery that reroutes blood around the liver). It can also happen in aplastic anemia (bone marrow failure) with very low platelet counts, in placental abruption (when the placenta separates from the uterus too early), in liver cirrhosis, and in some cancers, including prostate, lung, stomach and cervical cancer. A further use is bleeding in the urinary tract after prostate or kidney removal surgery, or bleeding linked to polycystic kidney disease or urinary tract cancers. Because it helps only when clot breakdown is part of the problem, the care team usually runs tests to confirm the cause of bleeding first. Off-label (outside its approved uses), it has been used to prevent bleeding after tooth extraction in people with hemophilia, although this rests on a few small, older studies, and sometimes for bleeding inside the eye after an injury. A closely related medicine, tranexamic acid, is often preferred today, particularly in heart bypass surgery, where head-to-head trials found it reduced blood loss and transfusions a little more.

How It Works

When a blood vessel is damaged, the body builds a clot to seal it. Later, the body dissolves that clot using an enzyme called plasmin, which is switched on from an inactive form (plasminogen) by substances called plasminogen activators. In some surgeries and illnesses, this clot-dissolving system becomes overactive and breaks clots down before the bleeding has stopped. Aminocaproic acid is a man-made relative of lysine, one of the amino acids that make up proteins. It mainly blocks the activation of plasminogen, and to a lesser degree blocks plasmin itself, so clots that have already formed stay in place longer. It does not create clots on its own and does not replace missing platelets or clotting factors, which is why people with hemophilia usually still need their factor treatment or another clotting treatment alongside it. The kidneys remove it from the body fairly quickly, with about half cleared every 2 hours, which is why it is given in frequent doses or as a continuous infusion.

Dosage & Administration

Aminocaproic acid comes as tablets (500 mg and 1,000 mg), an oral solution containing 250 mg in each milliliter, and an injection that hospital staff dilute and give through an IV. For sudden bleeding caused by excess clot breakdown, the label describes a larger dose during the first hour, followed by a smaller dose every hour, usually for about 8 hours or until the bleeding is controlled. For ongoing bleeding, prescribers may space doses every 3 to 6 hours and reduce the dose as bleeding settles. Tablets and liquid can follow the same schedule, but the exact amounts depend on the situation, so follow the prescription rather than a general schedule. In the hospital, the IV form is given slowly as an infusion, because a fast injection can lower blood pressure and slow the heart. At home, shake the liquid well before measuring it with a proper dosing device. If a dose is missed, take it when remembered unless the next one is almost due, and never double up.

Side Effects

The more common effects are nausea, vomiting, stomach pain, diarrhea, headache, dizziness and swelling in the legs or feet. Less often, people notice confusion, ringing in the ears, blurred or reduced vision, or a rash. With longer use, it can rarely damage muscle. This can start as muscle aches, weakness and tiredness and, in severe cases, cause muscle breakdown that turns urine dark or rust-colored and harms the kidneys. Contact the care team right away about new muscle weakness, dark urine or passing much less urine. Because the medicine keeps clots from dissolving, it can rarely contribute to a dangerous clot. Pain, warmth or swelling in one leg can signal a clot in a leg vein; call the care team promptly. Sudden chest pain, shortness of breath or coughing up blood can signal a clot in the lungs. Sudden weakness on one side of the body or trouble speaking can signal a stroke. Either needs emergency care right away (call 911).

Interactions & Warnings

Because aminocaproic acid keeps clots from dissolving, it is not used when the body is already forming clots throughout the bloodstream. In a serious condition called disseminated intravascular coagulation (DIC), widespread clotting uses up clotting factors and causes bleeding at the same time; aminocaproic acid must not be given in DIC unless heparin, a blood thinner, is given with it. It is generally avoided for bleeding that comes from the kidneys or ureters (the tubes that carry urine to the bladder), because clots that would normally dissolve can block urine flow and damage the kidney. So for blood in the urine, where the bleeding starts matters: when it comes from the kidney itself, as it can in polycystic kidney disease, the care team uses aminocaproic acid only if it judges the benefit worth the risk. It should not be combined with factor IX complex concentrates or anti-inhibitor coagulant concentrates, clotting products used in some people with hemophilia, because the risk of dangerous clots may rise. Tell the prescriber about any past blood clots and any kidney, heart or liver disease. The kidneys clear this drug, so in severe kidney failure it builds up and the dose may need adjusting. It has not been well studied in pregnancy or breastfeeding and is used in pregnancy only when clearly needed. Its safety and effectiveness in children have not been established on the US label, so use in children is a specialist decision.

What to Expect

Most courses are short, often hours to a few days, and many people receive aminocaproic acid in the hospital during or after surgery or a bleeding episode. It is stopped once the bleeding is under control. It can reduce bleeding and the need for transfusion, but it does not fix the underlying cause, so serious bleeding may still need transfusion or other treatment. Blood tests help confirm that excess clot breakdown is driving the bleeding and track how treatment is going. People who take it for longer stretches usually have a blood test for CK (creatine kinase), an enzyme released from damaged muscle; a rising CK level is a reason to stop the medicine. When it is used at home, for example before or after dental work in a bleeding disorder, the care team will set a clear start and stop plan.

Questions to Ask Your Doctor

  1. 1.What tests show that clot breakdown is contributing to my bleeding, and what happens if they do not?
  2. 2.Why aminocaproic acid rather than tranexamic acid for my situation?
  3. 3.How long should I take it, and how will we know when to stop?
  4. 4.Do my other treatments, such as clotting factor products, or my kidney function change how it should be used?
  5. 5.Which clot or muscle-related symptoms should I watch for during the course, and which need emergency care?

Last reviewed • Oct 2026

Educational content, not medical advice.